Advanced Solid Tumors | Norton Healthcare

Indication: Advanced Solid Tumors

A PHASE 1/2 DOSE ESCALATION AND DOSE EXPANSION STUDY OF BA3021 ALONE AND IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS

Sub-indication: Miscellaneous Malignancies

Drug Study

Principal Investigator: Jaspreet Grewal, M.D.
Norton Cancer Institute

Sponsor: BioAtla LLC

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.